Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
View analytic
Thursday, April 28 • 6:00pm - 7:30pm
The Evolving State of Relapsed/Refractory Multiple Myeloma Treatment

Sign up or log in to save this to your schedule and see who's attending!

In 2015 four new agents were approved for the treatment of multiple myeloma (MM) in the salvage setting, equipping oncology health professionals with more therapeutic options than ever before. But for oncology nurses, this progress also brings the challenge of managing new treatment-related toxicities. Through the use of iPad-based–learning elements, this interactive symposium will provide current information that will help oncology nurses maximize treatment outcomes for patients with relapsed/refractory MM.

Support for this activity has been provided through educational grants from Amgen, Bristol-Myers Squibb, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Please click here to register for this event.